Objectives: In vivo investigation of nitric oxide release in coronary bypass grafts has not been reported. We studied acetylcholine-induced nitric oxide release in viw) of coronary bypass grafts and vasomotor responses to acetylcholine of grafted coronary arteries in patients after coronary bypass grafting. Methods': We examined 24 internal thoracic artery grafts and 16 saphenous vein grafts in 39 patients. The mean ages of the patients were 65 years for the arterial grafts and 68 years for the venous grafts. Nitric oxide was measured as the plasma nitrite level by the Griess reaction. Before and after intragraft acetylcholine infusion (5 gtg), blood was sampled from the distal end of the graft, and angiograms were taken and analyzed by cine-densitometry. Results: The plasma nitrite concentration after stimulation with acetylcholine compared with the control value was 134% -52% at 4 minutes (p = 0.05) and 184% -107% at 6 minutes (p = 0.01) in the arterial grafts; in the venous grafts these values were 101% -24% at 4 minutes (p = 0.96) and 108% -36% at 6 minutes (p = 0.69). Low-dose acetylcholine dilated the coronary arteries supplied by arterial grafts by 6.3% -16.6% whereas coronary arteries supplied by venous grafts were reduced by 9.8% ---11.8% in diameter and the vasoactive responses were different (p = 0.01). Conclusions: In vivo internal thoracic artery grafts had more endothelium-derived nitric oxide release in response to acetylcholine than did saphenous vein grafts after coronary bypass grafting. (J Thorac Cardiovasc Surg 1998;116:454-9) From the
A rterial grafts, especially internal thoracic artery (ITA) grafts, recently have been used more often instead of saphenous vein grafts (SVGs) as the first choice for coronary artery revascularization] There are many reports that present the advantages of ITA grafts over venous grafts. First, ITA grafts have excellent patency and superior resistance to atherosclerotic changes over the long-term postoperative period. 2 Second, they adapt physiologically to the flow demands of coronary circulation 3 and adapt anatomically to physical development in pediatric patients. 4 These advantages are derived mainly from the viability of the ITA grafts. 5 In organ bath experiments, endothelial function in freshly harvested ITAs and saphenous veins in the grafted or ungrafted state differed with respect to the release of nitric oxide (NO). 6-s In vivo investigation of NO release in implanted coronary bypass grafts, however, has not yet been reported. The purpose of this study was to compare the acetylcholine-induced endothelial NO release in bypass grafts between ITAs and saphenous veins in patients after coronary artery bypass grafting and to evaluate the metabolic function of arterial and venous grafts.
Patients and methods
Patients. In 39 patients (36 men and 3 women), 40 bypass grafts were studied during postoperative cardiac catheterization. Patients with any signs of ischemia, angina, heart failure, or stenosis of the bypass grafts were excluded from the study protocol. Patient profiles are shown in Table I . The mean age and mean postoperative period for the patients at the time of this study were 65 + 9 years (range 47 to 78 years) and 38 ± 46 months (range 1 to 154 months), respectively, for the ITA graft group and 68 + 4 years (range 60 to 75 years) and 48 + 50 months (range 1 to 152 months), respectively, for the SVG group. There were no significant differences between the two groups in age, gender, postoperative period, or coronary risk factors including hypertension, diabetes mellitus, hyperlipidemia, and smoking history. All of the grafts were used as isolated grafts and all ITAs (19 left ITAs and 5 right ITAs) were used as in situ grafts. For the grafts bypassed to the left circumflex coronary artery (LCX), there were also no significant differences between the two groups in clinical profiles including age, postoperative period, and coronary risk factors. All grafts were anglographically patent with good run-off flow.
Study protocol. The study protocol was approved by the Institutional Review Committee on Human Research of Nara Medical University. Informed consent was obtained from the patients before the procedure and all the studies were completed without complications. Patients underwent cardiac catheterization while in a fasting state without premedication, after interruption of all vasoactive drugs for more than 24 hours. No patients received /3-adrenergic receptor blockers within 48 hours before the study. After postoperative diagnostic catheterization, a 5F Judkins catheter for the right coronary artery was positioned at the ostium of the coronary bypass graft, and grafts were selectively cannulated to the distal anastomotic site with a 2.7F microcatheter (Tracker-f8 infusion catheter, Target Therapeutics) through a guiding catheter. Blood in the distal portion of the graft was obtained through the microcatheter as a control. Blood was aspirated through the microcatheter over about 60 to 90 seconds to avoid hemolysis. Five micrograms or 3 × 10 -s tool of acetylcholine solution was then infused into the graft through the guiding catheter for 30 seconds. Blood samples from the distal portion of the graft were obtained in the same manner as for the control, at 4 and 6 minutes 'after the administration of acetylcholine. Eight minutes after the beginning of ace@choline administration, angiography of the grafts and the bypassed coronary arteries was performed. Angiograms were not taken in the first live patients in the SVG group or in the first six in the ITA group, but in the remaining patients angiographic inves-tigations were consecutively performed and the diameters of grafts and coronary arteries at points about 1 cm upstream and downstream from the anastomotic site were measured by cine-densitometry. The electrocardiogram and arterial pressure were monitored continuously during the procedures. Finally, I mg isosorbide dinitrate was injected into the graft through the guiding catheter to overcome the acetylcholine-induced vasoconstriction.
Assay of NO concentrations. Blood samples were obtained through the catheters with the use of disposable syringes and centrifuged as soon as possible at 3000 rpm for 5 minutes at 4 ° C. Plasma was stored at -80 ° C until use. Plasma samples were diluted 1:2 with deionized water and filtered through a 0.45 p~m microfilter. Plasma nitrite (NO2) and nitrate (NOr) concentrations were measured with an NOx analyzer (Enol0, Eicom, Kyoto, Japan) with high-performance liquid chromatography and the Griess reaction.9.1o In brief, the samples were first passed through a column to separate NOr from NO2-. Then the samples were passed through a second column containing copper-coated cadmium to reduce the NOr to NOr. Next the NO 2 was detected by reaction with the Griess reagent (0.03 mol/L sulfanilamide plus 0.15 mol/L HC1 solution containing 1.0 × 10 -3 mol/L N-[1-naphthyl] ethylenediamine). Absorption was measured at 546 nln with use of a spectrophotometer. Thus the separate NO2-and NOB " levels could be measured simultaneously. The detection limit of the assay was 1.0 × 10 -8 mol/L. 
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Results
Plasma NO 2-and NO 3-concentrations. For 40 grafts in 39 patients who had undergone coronary artery bypass grafting, the plasma NO 2 and NO 3 concentrations in the distal portion of the graft after acetylcholine administration are shown in Table II . Plasma NO 2 concentration significantly increased after acetylcholine infusion in the ITA grafts (at 4 minutes, p = 0.05; at 6 minutes, p = 0.01), whereas there were no significant increases for the SVGs (at 4 minutes, p = 0.96; at 6 minutes, p = 0.69). The response in plasma NO2-levels after stimulation with acetylcholine was different between ITA grafts and SVGs (at 4 minutes, p = 0.04; 6 minutes, p = 0.03). The plasma concentration of total NO 2-plus NO 3-also responded differently to the stimulation of acetylcholine between the two groups (at 4 minutes, p = 0.03; 6 minutes, p = 0.01). Significance of the difference in plasma NO 2 concentrations between the ITA grafts and SVGs was statistically borderline by analysis of variance Co = 0.05). A significant relation existed in the ratio of plasma level of NO 2-to total NO 2 plus NO 3-6 minutes after stimulation with acetylcholine Co = 0.05).
Because the target coronary arteries of the ITA or SVG differed, and the ITA was mainly used for the left anterior descending coronary artery and the SVG was mainly used for the right coronary artery NO Fig. 2 . The relation between the change in nitrite level after acetylcholine infusion and the graft age (period between graft implantation and the study). There was no significant correlation by regression analysis between the change of plasma NO 2 level after acetylcholine infusion and the graft age. and LCX as shown in Table I , NO 2 responses were compared in the bypass grafts for the LCX where both the ITA and SVG were used. The plasma NO2 concentration after stimulation with acetylcholine compared with the control value was different between the 1TA and SVG (at 4 minutes, p = 0.04; at 6 minutes, p = 0.01) (Fig. 1) . The increase in plasma NO 2-levels after stimulation with acetylcholine in the ITAs did not reach statistical significance.
Time between the graft implantation and the study ranged from 1 to 154 months for the ITA group and from 1 to 152 months for the SVG group. However, NO release induced by acetylcholine administration did not differ with regard to the graft age. There were no significant correlations or significant differences by regression analysis between the graft age and ratio of plasma NO 2-after stimulation with acetylcholine ( Fig. 2) .
Vasomotor response to acetylcholine. Fig. 3 shows angiograms of an SVG implanted to the LCX in a 65-year-old man 115 months after bypass grafting in the control condition and after intragraft infusion of 5/~g acetylcholine. The native coronary artery was constricted after acetylcholine administration. Fig. 4 shows angiograms of an ITA graft implanted to the left anterior descending artery in a 52-year-old man 145 months after bypass grafting in the control condition and after intragraft infusion of 5 /,g ace@choline. The native coronary artery was dilated after acetylcholine administration.
Low-dose acetylcho/ine dilated ITA grafts by 6.3% +_ 11.6% whereas SVGs were reduced by 3.1% (Fig. 5 ).
Low-dose acetylcholine dilated the coronary arteries supplied by arterial grafts by 6.3% _+ 16.6% whereas coronary arteries supplied by venous grafts were reduced by 9.8% _+ 11.8% in diameter. Acetylcholine-induced vasoconstriction was significantly less in the coronary arteries grafted with ITAs than in those with SVGs (p = 0.01) ( Fig. 6 ).
Discussion
Advantages of the ITA graft over the SVG are excellent patency, lower incidence of graft disease in the long-term postoperative period, and physiologic and anatomic adaptability. 12q~' These advantages are apparently a result of the properties of the vessel, especially of the endothelium. In organ bath experiments, endothelial release of NO was different in ITAs and SVGs in the grafted or ungrafted states] ~'-18 In this study, we demonstrated for the first time a greater release of NO in the ITA graft than in the SVG in patients 41 _+_ 47.3 months after coronary artery bypass grafting.
NO assay. NO cannot be easily or directly measured in biologic tissues or fluids because it is rapidly metabolized. Instead, NO concentration is determined by measurement of NO 2-and NO 3 concentrations. Determination of total plasma NO 2-plus N O 3-concentrations as a measurement of NO con.centration has been previously described and is a well established method. ~2'13 Although NO 2 and NO 3 are metabolites of NO, the metabolic rate of conversion of NO to NO e-or NO 3-in the blood is not presently known. Plasma NO 2 concentration is very low and previous assays rarely succeeded in the measurement of isolated plasma NO a level as a measurement of NO production. 14 Our measurements of separate plasma NO e and NO 3 concentrations were made with instrumentation incorporating high-performance liquid chromatography and the Griess reaction, which enabled separate evaluation of changes in plasma NO e-and NO 3-concentrations.9, 10 NO is released bidirectionally by the endotheliurn. 15 Extraluminal NO acts on the underlying vascular smooth muscle 16 and inhibits smooth muscle cell proliferation. Intraluminal NO is released into the blood. The results of the concentration measurements of metabolites in the present study demonstrated that the ITA graft actually released NO into the blood in response to acetylcholine. The NOreleasing response to acetylcholine was also better for the ITA grafts to the LCX as compared with that of the SVG for the same arterial lesions. There seem to be no differences in the ability of the graft to produce NO regardless of which coronary artery is targeted.
NO plays an important role in many physiologic functions. NO inhibits platelet aggregation and promotes platelet disaggregation. 17 It also inhibits platelet and leukocyte adhesions to the endotheliurn, ts protecting the endothelium from injury induced by superoxide radicals; in addition, intralumi- 6 . Vasomotor responses of the grafted coronary arteries to acetylcholine (ACH) infusion. Acetylcholineinduced vasoconstriction was significantly less in the coronary arteries grafted with ITA grafts than in those grafted with SVGs (p = 0.01).
nally released NO may have a metabolic effect on the downstream vascular beds. 19 Therefore ITA grafts with NO-releasing endothelium may have an antiatherosclerotic effect on both grafts and grafted coronary arteries. Vasomotor response to aeetyleholine. ITAs are usually free of atherosclerotic changes 2° and dilate in response to local administration of acetylcholine as long as the endothelium is functional. 21 The results of the NO assay offer an explanation for the graft's response to acetylcholine. The endothelial release of NO in SVGs was insufficient to reverse the direct constrictive effect of acetylcholine. Here we have provided quantitative data comparing the response to intragraft administration of low-dose acetylcholine of coronary arteries grafted with the ITA and SVG. The results are consistent with those of a previous angiographic study that examined the vasomotor response of grafts and coronary arteries grafted with ITAs to the administration of ergonovine or substance p.22, 23 However, high-dose acetylcholine administration can uniformly induce a constrictive response of the coronary artery, and a dilative response can be induced by an optimal dose of acetylcholine. 24 Several reasons for the dilation of the coronary arteries bypassed with ITA grafts in this study can be considered. First, intraluminally released NO from the graft can affect the downstream coronary arteries; second, endothelium-dependent NO-mediated dilation of the coronary ar-tery occurs in response to acetylcholine; and third, flow-mediated vasodilation after the increased flow of the graft occurs in response to acetylcholine or the angiographic procedures. Although we cannot exclude other mechanisms of coronary artery dilation such as an involvement of prostacyclin 2s or endothelium-dependent hyperpolarization factor, 2(' the results of the NO assay in the present study offer an explanation of the coronary artery response by the endothelium-derived NO from the grafts. The present angiographic results may suggest that the ITA graft has a possible metabolic effect of protecting the grafted coronary arteries from spasm and atherosclerosis.
In summary, the ITA graft is not only an excellent conduit with good long-term patency, but it also has a potential metabolic effect that protects the graft and the grafted coronary arteries from spasm and atherosclerosis. This is the first study to demonstrate in human subjects that in situ ITA grafts can produce more NO compared with venous grafts after coronary bypass grafting. Thus coronary artery bypass grafting with the ITA may have the salutary effect of transplanting functional endothelial cells into the coronary circulation.
